Dosage regimen with (s)-4,5-dihydro-2-[2-hydroxy-4-(3,6- dioxaheptyloxy)phenyl1-4-methyl-4-thiazolecarboxylic acid for use in the treatment of iron overload
AL13575BActive Publication Date: 2026-07-01ABFERO PHARMACEUTICALS INC +1
0 Cites 0 Cited by
Patent Information
- Application Number
- AL2026180
- Authority / Receiving Office
- AL · AL
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2026-03-17
- Publication Date
- 2026-07-01
- Estimated Expiration
- 2046-03-17
Need to check novelty before this filing date? Find Prior Art
No text content released.